Home-Based Testing Firm EverlyWell Raises $50M

Apr 16, 2019

|

NEW YORK (360Dx) – Home-based testing firm EverlyWell today announced it had raised $50 million to expand its digital platform and scale existing partnerships with companies including CVS and Humana.

The financing was led by existing investor Goodwater Capital. Highland Capital Partners also participated in the financing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Home-Based Testing Firm EverlyWell Raises $50M

To read the full story....

Breaking News

Myriad Genetics Settles Improper Medicare Billing Complaint for $9.1M

Lab, Healthcare Stakeholders Write Congress to Support Bill Revamping PAMA Lab Payment Reporting

In Brief This Week: Quest Diagnostics, Novacyt, HTG Molecular, and More

Theradiag Posts 9 Percent Increase in H1 2019 Revenues

Visceral Leishmaniasis Tests Lack Accuracy, Study Finds

Seer Raises $17.5 M in Series C Financing Round

What's Popular?

Myriad Genetics Settles Improper Medicare Billing Complaint for $9.1M

Startup Cradle Genomics Raises $17.1M in Series A Round to Develop NIPT

Seer Raises $17.5 M in Series C Financing Round

Parkinson's Foundation, Fulgent Genetics Partner on Genetic Testing Initiative

Abbott Q2 Diagnostics Revenues Rise 2 Percent, MDx Revenues Down 12 Percent

Sponsorships